Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
3.640
-0.250 (-6.43%)
At close: Jul 19, 2024, 12:00 AM
3.850
+0.210 (5.77%)
Pre-market: Jul 22, 2024, 8:47 AM EDT

Heart Test Laboratories Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Year Ending
TTM Apr 30, 2023Apr 30, 2022Apr 30, 2021Apr 30, 2020
Net Income
-6.39-6.35-4.83-2.45-3.81
Depreciation & Amortization
0.030.030.030.030.06
Share-Based Compensation
0.430.250.070.020.14
Other Operating Activities
-0.460.311.09-0.06-0.23
Operating Cash Flow
-6.4-5.77-3.64-2.45-3.84
Capital Expenditures
-0.02-0.02-0-00.01
Investing Cash Flow
-0.02-0.02-0-00.01
Share Issuance / Repurchase
11.426.77000
Debt Issued / Paid
-0-0.44.232.480.63
Other Financing Activities
0.150.17-0.390.21.18
Financing Cash Flow
11.566.533.842.681.81
Net Cash Flow
5.150.740.190.23-2.02
Free Cash Flow
-6.42-5.79-3.65-2.45-3.83
Free Cash Flow Margin
-34509.47%-112463.79%-25367.54%-9580.56%-5970.25%
Free Cash Flow Per Share
-11.93-72.85-109.86-74.02-115.63
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).